| Year |
Citation |
Score |
| 2023 |
Bhat AM, Mohapatra BC, Luan H, Mushtaq I, Chakraborty S, Dutta S, Storck MD, Meza JL, Lin MF, Cook LM, Corey E, Morrissey C, Coulter DW, Jordan Rowley M, Datta K, et al. Role of GD2 and its biosynthetic enzyme GD3 synthase in prostate cancer tumorigenesis. Biorxiv : the Preprint Server For Biology. PMID 36993422 DOI: 10.1101/2023.03.18.533299 |
0.518 |
|
| 2022 |
Miller DR, Ingersoll MA, Chou YW, Kosmacek EA, Oberley-Deegan RE, Lin MF. Dynamics of antioxidant heme Oxygenase-1 and pro-oxidant p66Shc in promoting advanced prostate cancer progression. Free Radical Biology & Medicine. PMID 36265795 DOI: 10.1016/j.freeradbiomed.2022.10.269 |
0.478 |
|
| 2021 |
Alpert E, Akhavan A, Gruzman A, Hansen WJ, Lehrer-Graiwer J, Hall SC, Johansen E, McAllister S, Gulati M, Lin MF, Lingappa VR. Multifunctionality of prostatic acid phosphatase in prostate cancer pathogenesis. Bioscience Reports. 41. PMID 34677582 DOI: 10.1042/BSR20211646 |
0.566 |
|
| 2021 |
Alpert E, Akhavan A, Gruzman A, Hansen WJ, Lehrer-Graiwer J, Hall SC, Johansen E, McAllister S, Gulati M, Lin MF, Lingappa VR. Multifunctionality of Prostatic Acid Phosphatase in Prostate Cancer Pathogenesis. Bioscience Reports. PMID 34605872 DOI: 10.1042/BCJ20200944 |
0.566 |
|
| 2021 |
Miller DR, Ingersoll MA, Teply BA, Lin MF. Targeting treatment options for castration-resistant prostate cancer. American Journal of Clinical and Experimental Urology. 9: 101-120. PMID 33816699 |
0.473 |
|
| 2020 |
Abdul-Rida NA, Farhan AM, Al-Masoudi NA, Saeed BA, Miller D, Lin MF. A novel pregnene analogs: synthesis, cytotoxicity on prostate cancer of PC-3 and LNCPa-AI cells and in silico molecular docking study. Molecular Diversity. PMID 32006297 DOI: 10.1007/s11030-020-10038-w |
0.429 |
|
| 2019 |
Miller DR, Ingersoll MA, Lin MF. ErbB-2 signaling in advanced prostate cancer progression and potential therapy Endocrine-Related Cancer. 26: R195-R209. PMID 31294537 DOI: 10.1530/ERC-19-0009 |
0.505 |
|
| 2019 |
Miller DR, Ingersoll MA, Chatterjee A, Baker B, Shrishrimal S, Kosmacek EA, Zhu Y, Cheng PW, Oberley-Deegan RE, Lin MF. p66Shc protein through a redox mechanism enhances the progression of prostate cancer cells towards castration-resistance. Free Radical Biology & Medicine. PMID 31100478 DOI: 10.1016/j.freeradbiomed.2019.05.015 |
0.566 |
|
| 2019 |
Miller D, Ingersoll M, Chatterjee A, Oberley-Deegan R, Lin M. Abstract 4285: p66Shc/ROS enhances the progression of androgen-sensitive towards castration-resistant prostate cancer cells Cancer Research. 79: 4285-4285. DOI: 10.1158/1538-7445.Am2019-4285 |
0.67 |
|
| 2018 |
Miller DR, Tzeng CC, Farmer T, Keller ET, Caplan S, Chen YS, Chen YL, Lin MF. Novel CIL-102 Derivatives as Potential Therapeutic Agents for Docetaxel-Resistant Prostate Cancer. Cancer Letters. PMID 30077739 DOI: 10.1016/J.Canlet.2018.07.039 |
0.496 |
|
| 2018 |
Ingersoll MA, Chou YW, Lin JS, Yuan TC, Miller D, Xie Y, Tu Y, Oberley-Deegan RE, Batra SK, Lin MF. p66Shc regulates migration of castration-resistant prostate cancer cells. Cellular Signalling. PMID 29462661 DOI: 10.1016/J.Cellsig.2018.02.008 |
0.745 |
|
| 2017 |
Miller DR, Ingersoll MA, Chou YW, Wakefield CB, Tu Y, Lin FF, Chaney WG, Lin MF. Anti-Androgen Abiraterone Acetate Improves the Therapeutic Efficacy of Statins on Castration-Resistant Prostate Cancer Cells. Journal of Oncology Research and Therapy. 3. PMID 31328181 |
0.566 |
|
| 2017 |
Bhat G, Hothpet VR, Lin MF, Cheng PW. Shifted Golgi targeting of glycosyltransferases and α-mannosidase IA from giantin to GM130-GRASP65 results in formation of high mannose N-glycans in aggressive prostate cancer cells. Biochimica Et Biophysica Acta. PMID 28782625 DOI: 10.1016/J.Bbagen.2017.08.006 |
0.629 |
|
| 2017 |
Chen L, Wolff DW, Xie Y, Lin MF, Tu Y. Cyproterone acetate enhances TRAIL-induced androgen-independent prostate cancer cell apoptosis via up-regulation of death receptor 5. Bmc Cancer. 17: 179. PMID 28270124 DOI: 10.1186/S12885-017-3153-4 |
0.584 |
|
| 2016 |
Zhang L, Qian H, Sha M, Luan Z, Lin M, Yuan D, Li X, Huang J, Ye L. Downregulation of HOTAIR Expression Mediated Anti-Metastatic Effect of Artesunate on Cervical Cancer by Inhibiting COX-2 Expression. Plos One. 11: e0164838. PMID 27736969 DOI: 10.1371/journal.pone.0164838 |
0.318 |
|
| 2016 |
Ingersoll MA, Miller DR, Martinez O, Wakefield CB, Hsieh KC, Simha MV, Kao CL, Chen HT, Batra SK, Lin MF. Statin Derivatives as Therapeutic Agents for Castration-Resistant Prostate Cancer. Cancer Letters. PMID 27687622 DOI: 10.1016/J.Canlet.2016.09.008 |
0.647 |
|
| 2016 |
Zhan K, Lin M, Zhao QM, Zhan JS, Zhao GQ. Biological characterization of bovine mammary epithelial cell lines immortalized by HPV16 E6/E7 and SV40T. In Vitro Cellular & Developmental Biology. Animal. PMID 27412498 DOI: 10.1007/s11626-016-0063-8 |
0.33 |
|
| 2016 |
Ingersoll MA, Muniyan S, Lin F, Yuan T, Chou Y, Batra SK, Lin M. Abstract 5069: p66Shc regulates the migration of castration-resistant prostate cancer Cancer Research. 76: 5069-5069. DOI: 10.1158/1538-7445.Am2016-5069 |
0.746 |
|
| 2015 |
Kaushik D, Vashistha V, Isharwal S, Sediqe SA, Lin MF. Histone deacetylase inhibitors in castration-resistant prostate cancer: molecular mechanism of action and recent clinical trials. Therapeutic Advances in Urology. 7: 388-395. PMID 26622323 DOI: 10.1177/1756287215597637 |
0.528 |
|
| 2015 |
Muniyan S, Chen SJ, Lin FF, Wang Z, Mehta PP, Batra SK, Lin MF. ErbB-2 signaling plays a critical role in regulating androgen-sensitive and castration-resistant androgen receptor-positive prostate cancer cells. Cellular Signalling. PMID 26257301 DOI: 10.1016/J.Cellsig.2015.08.002 |
0.768 |
|
| 2015 |
Chou YW, Lin FF, Muniyan S, Lin FC, Chen CS, Wang J, Huang CC, Lin MF. Cellular prostatic acid phosphatase (cPAcP) serves as a useful biomarker of histone deacetylase (HDAC) inhibitors in prostate cancer cell growth suppression. Cell & Bioscience. 5: 38. PMID 26185616 DOI: 10.1186/s13578-015-0033-y |
0.576 |
|
| 2015 |
Ingersoll MA, Lyons AS, Muniyan S, D'Cunha N, Robinson T, Hoelting K, Dwyer JG, Bu XR, Batra SK, Lin MF. Novel Imidazopyridine Derivatives Possess Anti-Tumor Effect on Human Castration-Resistant Prostate Cancer Cells. Plos One. 10: e0131811. PMID 26121643 DOI: 10.1371/Journal.Pone.0131811 |
0.536 |
|
| 2015 |
Mimeault M, Rachagani S, Muniyan S, Seshacharyulu P, Johansson SL, Datta K, Lin MF, Batra SK. Inhibition of hedgehog signaling improves the anti-carcinogenic effects of docetaxel in prostate cancer. Oncotarget. 6: 3887-903. PMID 25682877 DOI: 10.18632/Oncotarget.2932 |
0.466 |
|
| 2015 |
Lo WF, Chou YW, Tseng CH, Shiu YH, Chen YW, Yang SC, Chen YL, Lin MF, Tzeng CC. Discovery of Novel N-alkyl 4-anilinofuro[2,3-b]quinoline Derivatives (CIL-102 Derivatives) Against Castration-resistant Human Prostate Cancers. Anti-Cancer Agents in Medicinal Chemistry. 15: 493-500. PMID 25612680 |
0.457 |
|
| 2015 |
Muniyan S, Chou YW, Tsai TJ, Thomes P, Veeramani S, Benigno BB, Walker LD, McDonald JF, Khan SA, Lin FF, Lele SM, Lin MF. p66Shc longevity protein regulates the proliferation of human ovarian cancer cells. Molecular Carcinogenesis. 54: 618-31. PMID 24395385 DOI: 10.1002/mc.22129 |
0.439 |
|
| 2014 |
Kelsey L, Katoch P, Ray A, Mitra S, Chakraborty S, Lin MF, Mehta PP. Vitamin D3 regulates the formation and degradation of gap junctions in androgen-responsive human prostate cancer cells. Plos One. 9: e106437. PMID 25188420 DOI: 10.1371/journal.pone.0106437 |
0.55 |
|
| 2014 |
Muniyan S, Chou YW, Ingersoll MA, Devine A, Morris M, Odero-Marah VA, Khan SA, Chaney WG, Bu XR, Lin MF. Antiproliferative activity of novel imidazopyridine derivatives on castration-resistant human prostate cancer cells. Cancer Letters. 353: 59-67. PMID 25050738 DOI: 10.1016/j.canlet.2014.07.002 |
0.628 |
|
| 2014 |
Muniyan S, Ingersoll MA, Batra SK, Lin MF. Cellular prostatic acid phosphatase, a PTEN-functional homologue in prostate epithelia, functions as a prostate-specific tumor suppressor. Biochimica Et Biophysica Acta. 1846: 88-98. PMID 24747769 DOI: 10.1016/J.Bbcan.2014.04.006 |
0.599 |
|
| 2014 |
Wang C, Zhao Q, Min J, Muniyan S, Vargas M, Wang X, Dong Y, Guy RK, Lin MF, Keiser J, Vennerstrom JL. Antischistosomal versus antiandrogenic properties of aryl hydantoin Ro 13-3978. The American Journal of Tropical Medicine and Hygiene. 90: 1156-8. PMID 24686741 DOI: 10.4269/Ajtmh.14-0029 |
0.413 |
|
| 2013 |
Fredericks WJ, Sepulveda J, Lai P, Tomaszewski JE, Lin MF, McGarvey T, Rauscher FJ, Malkowicz SB. The tumor suppressor TERE1 (UBIAD1) prenyltransferase regulates the elevated cholesterol phenotype in castration resistant prostate cancer by controlling a program of ligand dependent SXR target genes. Oncotarget. 4: 1075-92. PMID 23919967 |
0.492 |
|
| 2013 |
Muniyan S, Chaturvedi NK, Dwyer JG, Lagrange CA, Chaney WG, Lin MF. Human prostatic Acid phosphatase: structure, function and regulation. International Journal of Molecular Sciences. 14: 10438-64. PMID 23698773 DOI: 10.3390/Ijms140510438 |
0.725 |
|
| 2013 |
Chou YW, Zhang L, Muniyan S, Ahmad H, Kumar S, Alam SM, Lin MF. Androgens upregulate Cdc25C protein by inhibiting its proteasomal and lysosomal degradation pathways. Plos One. 8: e61934. PMID 23637932 DOI: 10.1371/journal.pone.0061934 |
0.539 |
|
| 2012 |
Veeramani S, Chou YW, Lin FC, Muniyan S, Lin FF, Kumar S, Xie Y, Lele SM, Tu Y, Lin MF. Reactive oxygen species induced by p66Shc longevity protein mediate nongenomic androgen action via tyrosine phosphorylation signaling to enhance tumorigenicity of prostate cancer cells. Free Radical Biology & Medicine. 53: 95-108. PMID 22561705 DOI: 10.1016/J.Freeradbiomed.2012.03.024 |
0.64 |
|
| 2012 |
Wolff DW, Xie Y, Deng C, Gatalica Z, Yang M, Wang B, Wang J, Lin MF, Abel PW, Tu Y. Epigenetic repression of regulator of G-protein signaling 2 promotes androgen-independent prostate cancer cell growth. International Journal of Cancer. Journal International Du Cancer. 130: 1521-31. PMID 21500190 DOI: 10.1002/Ijc.26138 |
0.65 |
|
| 2011 |
Hong SK, Kim JH, Lin MF, Park JI. The Raf/MEK/extracellular signal-regulated kinase 1/2 pathway can mediate growth inhibitory and differentiation signaling via androgen receptor downregulation in prostate cancer cells. Experimental Cell Research. 317: 2671-82. PMID 21871886 DOI: 10.1016/j.yexcr.2011.08.008 |
0.499 |
|
| 2011 |
Chou YW, Chaturvedi NK, Ouyang S, Lin FF, Kaushik D, Wang J, Kim I, Lin MF. Histone deacetylase inhibitor valproic acid suppresses the growth and increases the androgen responsiveness of prostate cancer cells. Cancer Letters. 311: 177-86. PMID 21862211 DOI: 10.1016/j.canlet.2011.07.015 |
0.57 |
|
| 2011 |
Wong CY, Wuriyanghan H, Xie Y, Lin MF, Abel PW, Tu Y. Epigenetic regulation of phosphatidylinositol 3,4,5-triphosphate-dependent Rac exchanger 1 gene expression in prostate cancer cells. The Journal of Biological Chemistry. 286: 25813-22. PMID 21636851 DOI: 10.1074/Jbc.M110.211292 |
0.576 |
|
| 2011 |
Radhakrishnan P, Chachadi V, Lin MF, Singh R, Kannagi R, Cheng PW. TNFα enhances the motility and invasiveness of prostatic cancer cells by stimulating the expression of selective glycosyl- and sulfotransferase genes involved in the synthesis of selectin ligands. Biochemical and Biophysical Research Communications. 409: 436-41. PMID 21596021 DOI: 10.1016/j.bbrc.2011.05.019 |
0.543 |
|
| 2011 |
Kumar S, Kumar S, Rajendran M, Alam SM, Lin FF, Cheng PW, Lin MF. Steroids up-regulate p66Shc longevity protein in growth regulation by inhibiting its ubiquitination. Plos One. 6: e15942. PMID 21264241 DOI: 10.1371/journal.pone.0015942 |
0.359 |
|
| 2011 |
Fredericks W, Sepulveda J, Lal P, Tomaszewski J, McGarvey T, Lin M, Chen T, Malkowicz S. 1620 THE TERE1(UBIAD1) PROTEIN REDUCES CHOLESTEROL IN C81-LNCAP PROSTATE CANCER CELLS: INDUCTION BY 1,25-OH VITAMIN D3 OR ECTOPIC EXPRESSION Journal of Urology. 185. DOI: 10.1016/j.juro.2011.02.1728 |
0.518 |
|
| 2010 |
Chuang TD, Chen SJ, Lin FF, Veeramani S, Kumar S, Batra SK, Tu Y, Lin MF. Human prostatic acid phosphatase, an authentic tyrosine phosphatase, dephosphorylates ErbB-2 and regulates prostate cancer cell growth. The Journal of Biological Chemistry. 285: 23598-606. PMID 20498373 DOI: 10.1074/Jbc.M109.098301 |
0.793 |
|
| 2010 |
Rajendran M, Thomes P, Zhang L, Veeramani S, Lin MF. p66Shc--a longevity redox protein in human prostate cancer progression and metastasis : p66Shc in cancer progression and metastasis. Cancer Metastasis Reviews. 29: 207-22. PMID 20111892 DOI: 10.1007/S10555-010-9213-8 |
0.65 |
|
| 2009 |
Veeramani S, Lee MS, Lin MF. Revisiting histidine-dependent acid phosphatases: a distinct group of tyrosine phosphatases. Trends in Biochemical Sciences. 34: 273-8. PMID 19467874 DOI: 10.1016/j.tibs.2009.03.002 |
0.49 |
|
| 2009 |
Zhang L, Davis JS, Zelivianski S, Lin FF, Schutte R, Davis TL, Hauke R, Batra SK, Lin MF. Suppression of ErbB-2 in androgen-independent human prostate cancer cells enhances cytotoxic effect by gemcitabine in an androgen-reduced environment. Cancer Letters. 285: 58-65. PMID 19467571 DOI: 10.1016/J.Canlet.2009.04.041 |
0.592 |
|
| 2009 |
Qin J, Xie Y, Wang B, Hoshino M, Wolff DW, Zhao J, Scofield MA, Dowd FJ, Lin MF, Tu Y. Upregulation of PIP3-dependent Rac exchanger 1 (P-Rex1) promotes prostate cancer metastasis. Oncogene. 28: 1853-63. PMID 19305425 DOI: 10.1038/Onc.2009.30 |
0.704 |
|
| 2009 |
Alam SM, Rajendran M, Ouyang S, Veeramani S, Zhang L, Lin MF. A novel role of Shc adaptor proteins in steroid hormone-regulated cancers. Endocrine-Related Cancer. 16: 1-16. PMID 19001530 DOI: 10.1677/ERC-08-0179 |
0.437 |
|
| 2009 |
Radhakrishnan P, Lin MF, Cheng PW. Elevated expression of L-selectin ligand in lymph node-derived human prostate cancer cells correlates with increased tumorigenicity. Glycoconjugate Journal. 26: 75-81. PMID 18670876 DOI: 10.1007/S10719-008-9167-Z |
0.65 |
|
| 2008 |
Dillard PR, Lin MF, Khan SA. Androgen-independent prostate cancer cells acquire the complete steroidogenic potential of synthesizing testosterone from cholesterol. Molecular and Cellular Endocrinology. 295: 115-20. PMID 18782595 DOI: 10.1016/j.mce.2008.08.013 |
0.673 |
|
| 2008 |
Veeramani S, Yuan TC, Lin FF, Lin MF. Mitochondrial redox signaling by p66Shc is involved in regulating androgenic growth stimulation of human prostate cancer cells. Oncogene. 27: 5057-68. PMID 18504439 DOI: 10.1038/Onc.2008.143 |
0.808 |
|
| 2008 |
Singh AP, Bafna S, Chaudhary K, Venkatraman G, Smith L, Eudy JD, Johansson SL, Lin MF, Batra SK. Genome-wide expression profiling reveals transcriptomic variation and perturbed gene networks in androgen-dependent and androgen-independent prostate cancer cells. Cancer Letters. 259: 28-38. PMID 17977648 DOI: 10.1016/J.Canlet.2007.09.018 |
0.619 |
|
| 2007 |
Mimeault M, Mehta PP, Hauke R, Henichart JP, Depreux P, Lin MF, Batra SK. Improvement of cytotoxic effects induced by mitoxantrone on hormone-refractory metastatic prostate cancer cells by co-targeting epidermal growth factor receptor and hedgehog signaling cascades. Growth Factors (Chur, Switzerland). 25: 400-16. PMID 18365871 DOI: 10.1080/08977190801930935 |
0.599 |
|
| 2007 |
Yuan TC, Veeramani S, Lin MF. Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells. Endocrine-Related Cancer. 14: 531-47. PMID 17914087 DOI: 10.1677/ERC-07-0061 |
0.777 |
|
| 2007 |
Yuan TC, Lin FF, Veeramani S, Chen SJ, Earp HS, Lin MF. ErbB-2 via PYK2 upregulates the adhesive ability of androgen receptor-positive human prostate cancer cells. Oncogene. 26: 7552-9. PMID 17563746 DOI: 10.1038/sj.onc.1210570 |
0.788 |
|
| 2007 |
Xie Y, Wolff DW, Lin MF, Tu Y. Vasoactive intestinal peptide transactivates the androgen receptor through a protein kinase A-dependent extracellular signal-regulated kinase pathway in prostate cancer LNCaP cells. Molecular Pharmacology. 72: 73-85. PMID 17430995 DOI: 10.1124/Mol.107.033894 |
0.675 |
|
| 2007 |
Mimeault M, Johansson SL, Vankatraman G, Moore E, Henichart JP, Depreux P, Lin MF, Batra SK. Combined targeting of epidermal growth factor receptor and hedgehog signaling by gefitinib and cyclopamine cooperatively improves the cytotoxic effects of docetaxel on metastatic prostate cancer cells. Molecular Cancer Therapeutics. 6: 967-78. PMID 17363490 DOI: 10.1158/1535-7163.Mct-06-0648 |
0.659 |
|
| 2007 |
Chen SJ, Karan D, Johansson SL, Lin FF, Zeckser J, Singh AP, Batra SK, Lin MF. Prostate-derived factor as a paracrine and autocrine factor for the proliferation of androgen receptor-positive human prostate cancer cells. The Prostate. 67: 557-71. PMID 17221842 DOI: 10.1002/Pros.20551 |
0.79 |
|
| 2007 |
Mimeault M, Venkatraman G, Johansson SL, Moore E, Henichart JP, Depreux P, Lin MF, Batra SK. Novel combination therapy against metastatic and androgen-independent prostate cancer by using gefitinib, tamoxifen and etoposide. International Journal of Cancer. Journal International Du Cancer. 120: 160-9. PMID 17013895 DOI: 10.1002/Ijc.22268 |
0.56 |
|
| 2007 |
Cai C, Chen SY, Zheng Z, Omwancha J, Lin MF, Balk SP, Shemshedini L. Androgen regulation of soluble guanylyl cyclasealpha1 mediates prostate cancer cell proliferation. Oncogene. 26: 1606-15. PMID 16964290 DOI: 10.1038/Sj.Onc.1209956 |
0.714 |
|
| 2007 |
Xie Y, Wolff DW, Lin M, Tu Y. Vasoactive intestinal peptide transactivates the androgen receptor through a PKA‐dependent extracellular signal‐regulated kinase pathway in prostate cancer cells The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A428-B |
0.627 |
|
| 2006 |
Yuan TC, Veeramani S, Lin FF, Kondrikou D, Zelivianski S, Igawa T, Karan D, Batra SK, Lin MF. Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells. Endocrine-Related Cancer. 13: 151-67. PMID 16601285 DOI: 10.1677/Erc.1.01043 |
0.796 |
|
| 2006 |
Singh AP, Chauhan SC, Bafna S, Johansson SL, Smith LM, Moniaux N, Lin MF, Batra SK. Aberrant expression of transmembrane mucins, MUC1 and MUC4, in human prostate carcinomas. The Prostate. 66: 421-9. PMID 16302265 DOI: 10.1002/Pros.20372 |
0.636 |
|
| 2006 |
Mimeault M, Moore E, Moniaux N, Hénichart JP, Depreux P, Lin MF, Batra SK. Cytotoxic effects induced by a combination of cyclopamine and gefitinib, the selective hedgehog and epidermal growth factor receptor signaling inhibitors, in prostate cancer cells. International Journal of Cancer. Journal International Du Cancer. 118: 1022-31. PMID 16108016 DOI: 10.1002/Ijc.21440 |
0.48 |
|
| 2005 |
Veeramani S, Yuan TC, Chen SJ, Lin FF, Petersen JE, Shaheduzzaman S, Srivastava S, MacDonald RG, Lin MF. Cellular prostatic acid phosphatase: a protein tyrosine phosphatase involved in androgen-independent proliferation of prostate cancer. Endocrine-Related Cancer. 12: 805-22. PMID 16322323 DOI: 10.1677/erc.1.00950 |
0.826 |
|
| 2005 |
Veeramani S, Igawa T, Yuan TC, Lin FF, Lee MS, Lin JS, Johansson SL, Lin MF. Expression of p66(Shc) protein correlates with proliferation of human prostate cancer cells. Oncogene. 24: 7203-12. PMID 16170380 DOI: 10.1038/sj.onc.1208852 |
0.773 |
|
| 2005 |
Stewart LV, Lyles B, Lin MF, Weigel NL. Vitamin D receptor agonists induce prostatic acid phosphatase to reduce cell growth and HER-2 signaling in LNCaP-derived human prostate cancer cells. The Journal of Steroid Biochemistry and Molecular Biology. 97: 37-46. PMID 16076555 DOI: 10.1016/j.jsbmb.2005.06.011 |
0.553 |
|
| 2004 |
Yuan TC, Lin MF. Protease-activated receptor 1: a role in prostate cancer metastasis. Clinical Prostate Cancer. 3: 189-91. PMID 15634362 |
0.573 |
|
| 2004 |
Zelivianski S, Glowacki R, Lin MF. Transcriptional activation of the human prostatic acid phosphatase gene by NF-kappaB via a novel hexanucleotide-binding site. Nucleic Acids Research. 32: 3566-80. PMID 15240830 DOI: 10.1093/Nar/Gkh677 |
0.626 |
|
| 2004 |
Lee MS, Igawa T, Lin MF. Tyrosine-317 of p52(Shc) mediates androgen-stimulated proliferation signals in human prostate cancer cells. Oncogene. 23: 3048-58. PMID 14990987 DOI: 10.1038/Sj.Onc.1207451 |
0.77 |
|
| 2004 |
Lee MS, Igawa T, Chen SJ, Van Bemmel D, Lin JS, Lin FF, Johansson SL, Christman JK, Lin MF. p66Shc protein is upregulated by steroid hormones in hormone-sensitive cancer cells and in primary prostate carcinomas. International Journal of Cancer. 108: 672-8. PMID 14696093 DOI: 10.1002/Ijc.11621 |
0.81 |
|
| 2003 |
Zhang XQ, Kondrikov D, Yuan TC, Lin FF, Hansen J, Lin MF. Receptor protein tyrosine phosphatase alpha signaling is involved in androgen depletion-induced neuroendocrine differentiation of androgen-sensitive LNCaP human prostate cancer cells. Oncogene. 22: 6704-16. PMID 14555984 DOI: 10.1038/sj.onc.1206764 |
0.791 |
|
| 2003 |
Karan D, Lin FC, Bryan M, Ringel J, Moniaux N, Lin MF, Batra SK. Expression of ADAMs (a disintegrin and metalloproteases) and TIMP-3 (tissue inhibitor of metalloproteinase-3) in human prostatic adenocarcinomas. International Journal of Oncology. 23: 1365-71. PMID 14532978 |
0.59 |
|
| 2003 |
Zelivianski S, Spellman M, Kellerman M, Kakitelashvilli V, Zhou XW, Lugo E, Lee MS, Taylor R, Davis TL, Hauke R, Lin MF. ERK inhibitor PD98059 enhances docetaxel-induced apoptosis of androgen-independent human prostate cancer cells. International Journal of Cancer. Journal International Du Cancer. 107: 478-85. PMID 14506750 DOI: 10.1002/ijc.11413 |
0.687 |
|
| 2003 |
Karan D, Chen SJ, Johansson SL, Singh AP, Paralkar VM, Lin MF, Batra SK. Dysregulated expression of MIC-1/PDF in human prostate tumor cells. Biochemical and Biophysical Research Communications. 305: 598-604. PMID 12763036 DOI: 10.1016/S0006-291X(03)00823-4 |
0.801 |
|
| 2003 |
Igawa T, Lin FF, Rao P, Lin MF. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase. The Prostate. 55: 247-58. PMID 12712404 DOI: 10.1002/Pros.10240 |
0.706 |
|
| 2003 |
Schaffer BS, Lin MF, Byrd JC, Park JH, MacDonald RG. Opposing roles for the insulin-like growth factor (IGF)-II and mannose 6-phosphate (Man-6-P) binding activities of the IGF-II/Man-6-P receptor in the growth of prostate cancer cells. Endocrinology. 144: 955-66. PMID 12586773 DOI: 10.1210/En.2002-220751 |
0.625 |
|
| 2003 |
Lee MS, Igawa T, Yuan TC, Zhang XQ, Lin FF, Lin MF. ErbB-2 signaling is involved in regulating PSA secretion in androgen-independent human prostate cancer LNCaP C-81 cells. Oncogene. 22: 781-96. PMID 12569372 DOI: 10.1038/Sj.Onc.1206066 |
0.837 |
|
| 2003 |
Karan D, Lin MF, Johansson SL, Batra SK. Current status of the molecular genetics of human prostatic adenocarcinomas. International Journal of Cancer. 103: 285-93. PMID 12471610 DOI: 10.1002/Ijc.10813 |
0.509 |
|
| 2003 |
Karan D, Lin FC, Bryan M, Ringel J, Moniaux N, Lin M, Batra SK. Expression of ADAMs (a disintegrin and metalloproteases) and TIMP-3 (tissue inhibitor of metalloproteinase-3) in human prostatic adenocarcinomas. International Journal of Oncology. 23: 1365-1371. DOI: 10.3892/Ijo.23.5.1365 |
0.651 |
|
| 2002 |
Bastola DR, Pahwa GS, Lin MF, Cheng PW. Downregulation of PTEN/MMAC/TEP1 expression in human prostate cancer cell line DU145 by growth stimuli. Molecular and Cellular Biochemistry. 236: 75-81. PMID 12190124 DOI: 10.1023/A:1016191913274 |
0.661 |
|
| 2002 |
Karan D, Kelly DL, Rizzino A, Lin MF, Batra SK. Expression profile of differentially-regulated genes during progression of androgen-independent growth in human prostate cancer cells. Carcinogenesis. 23: 967-75. PMID 12082018 DOI: 10.1093/Carcin/23.6.967 |
0.656 |
|
| 2002 |
Zelivianski S, Igawa T, Lim S, Taylor R, Lin MF. Identification and characterization of regulatory elements of the human prostatic acid phosphatase promoter. Oncogene. 21: 3696-705. PMID 12032838 DOI: 10.1038/Sj.Onc.1205471 |
0.699 |
|
| 2002 |
Igawa T, Lin FF, Lee MS, Karan D, Batra SK, Lin MF. Establishment and characterization of androgen-independent human prostate cancer LNCaP cell model. The Prostate. 50: 222-35. PMID 11870800 DOI: 10.1002/Pros.10054 |
0.792 |
|
| 2001 |
Lin MF, Lee MS, Zhou XW, Andressen JC, Meng TC, Johansson SL, West WW, Taylor RJ, Anderson JR, Lin FF. Decreased expression of cellular prostatic acid phosphatase increases tumorigenicity of human prostate cancer cells. The Journal of Urology. 166: 1943-50. PMID 11586265 |
0.814 |
|
| 2001 |
Karan D, Johansson SL, Lin MF, Batra SK. Expression of tumor-associated glycoprotein-72 (TAG-72) antigen in human prostatic adenocarcinomas. Oncology Reports. 8: 1123-6. PMID 11496328 DOI: 10.3892/Or.8.5.1123 |
0.593 |
|
| 2001 |
Zhang XQ, Lee MS, Zelivianski S, Lin MF. Characterization of a prostate-specific tyrosine phosphatase by mutagenesis and expression in human prostate cancer cells. The Journal of Biological Chemistry. 276: 2544-50. PMID 11067847 DOI: 10.1074/Jbc.M006661200 |
0.756 |
|
| 2000 |
Lin MF, Lee MS, Garcia-Arenas R, Lin FF. Differential responsiveness of prostatic acid phosphatase and prostate-specific antigen mRNA to androgen in prostate cancer cells. Cell Biology International. 24: 681-9. PMID 11023645 DOI: 10.1006/Cbir.2000.0433 |
0.798 |
|
| 2000 |
Zelivianski S, Dean J, Madhavan D, Lin FF, Lin MF. Expression of receptor protein tyrosine phosphatase α mRNA in human prostate cancer cell lines Molecular and Cellular Biochemistry. 208: 11-18. PMID 10939623 DOI: 10.1023/A:1007010304194 |
0.625 |
|
| 2000 |
Meng TC, Lee MS, Lin MF. Interaction between protein tyrosine phosphatase and protein tyrosine kinase is involved in androgen-promoted growth of human prostate cancer cells. Oncogene. 19: 2664-77. PMID 10851066 DOI: 10.1038/Sj.Onc.1203576 |
0.812 |
|
| 2000 |
Zelivianski S, Larson C, Seberger J, Taylor R, Lin M. Expression of human prostatic acid phosphatase gene is regulated by upstream negative and positive elements. Biochimica Et Biophysica Acta. 1491: 123-132. PMID 10760575 DOI: 10.1016/S0167-4781(00)00037-3 |
0.483 |
|
| 1998 |
Zelivianski S, Comeau D, Lin M. Cloning and analysis of the promoter activity of the human prostatic acid phosphatase gene. Biochemical and Biophysical Research Communications. 245: 108-112. PMID 9535792 DOI: 10.1006/Bbrc.1998.8386 |
0.645 |
|
| Show low-probability matches. |